menu search

Novavax inks lofty covid-19 vaccine deal with israel

Novavax, Inc. (NASDAQ:NVAX ) was last seen up 1.6% at $74.25, after Israel inked a deal with the biotechnology concern to buy 5 million of its Covid-...

January 28, 2022, 10:27 am

Novavax inks lofty covid-19 vaccine deal with israel

Novavax, Inc. (NASDAQ:NVAX ) was last seen up 1.6% at $74.25, after Israel inked a deal with the biotechnology concern to buy 5 million of its Covid-...

January 28, 2022, 10:27 am

Better biotech stock: crispr therapeutics or twist bioscience?

One of these biotech stocks could have more room to run than the other....

January 28, 2022, 9:15 am

Better biotech stock: crispr therapeutics or twist bioscience?

One of these biotech stocks could have more room to run than the other....

January 28, 2022, 9:15 am

Better biotech stock: crispr therapeutics or twist bioscience?

One of these biotech stocks could have more room to run than the other....

January 28, 2022, 9:15 am

Why sorrento therapeutics stock is getting hammered this week

Despite positive material updates, the biotech's shares couldn't escape the market-wide downturn among growth stocks this week....

January 28, 2022, 8:30 am

Why sorrento therapeutics stock is getting hammered this week

Despite positive material updates, the biotech's shares couldn't escape the market-wide downturn among growth stocks this week....

January 28, 2022, 8:30 am

Why sorrento therapeutics stock is getting hammered this week

Despite positive material updates, the biotech's shares couldn't escape the market-wide downturn among growth stocks this week....

January 28, 2022, 8:30 am

3 biotechs that will soar regardless of covid-19

In the healthcare markets, much time and energy have been focused on COVID-19. But there are some amazing opportunities outside the COVID space....

January 27, 2022, 6:23 pm

3 biotechs that will soar regardless of covid-19

In the healthcare markets, much time and energy have been focused on COVID-19. But there are some amazing opportunities outside the COVID space....

January 27, 2022, 6:23 pm

3 biotechs that will soar regardless of covid-19

In the healthcare markets, much time and energy have been focused on COVID-19. But there are some amazing opportunities outside the COVID space....

January 27, 2022, 6:23 pm

Zymeworks aims to raise $100m in public offering amid leadership shakeup

Zymeworks is looking to raise $100 million in a public offering, barely a week since new CEO Kenneth Galbraith took the reins of the ...

January 27, 2022, 5:43 pm

Zymeworks aims to raise $100m in public offering amid leadership shakeup

Zymeworks is looking to raise $100 million in a public offering, barely a week since new CEO Kenneth Galbraith took the reins of the ...

January 27, 2022, 5:43 pm

Zymeworks aims to raise $100m in public offering amid leadership shakeup

Zymeworks is looking to raise $100 million in a public offering, barely a week since new CEO Kenneth Galbraith took the reins of the ...

January 27, 2022, 5:43 pm

Johnson & johnson hunting for biotech, medical device acquisitions

Johnson & Johnson ( JNJ , Financial) is on the lookout for medical device and biotech companies to add ...

January 27, 2022, 4:57 pm

Johnson & johnson hunting for biotech, medical device acquisitions

Johnson & Johnson ( JNJ , Financial) is on the lookout for medical device and biotech companies to add ...

January 27, 2022, 4:57 pm

Johnson & johnson hunting for biotech, medical device acquisitions

Johnson & Johnson ( JNJ , Financial) is on the lookout for medical device and biotech companies to add ...

January 27, 2022, 4:57 pm

Wellbeing says its subsidiary kgk science partners with nova mentis for developing psychedelic drug portfolio

Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc, formerly known as Ketamine One, announced that its wholly-owned subsidiary, KGK Science In...

January 27, 2022, 9:04 am

Wellbeing says its subsidiary kgk science partners with nova mentis for developing psychedelic drug portfolio

Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc, formerly known as Ketamine One, announced that its wholly-owned subsidiary, KGK Science In...

January 27, 2022, 9:04 am

Wellbeing says its subsidiary kgk science partners with nova mentis for developing psychedelic drug portfolio

Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc, formerly known as Ketamine One, announced that its wholly-owned subsidiary, KGK Science In...

January 27, 2022, 9:04 am


Search within

Pages Search Results: